Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Quanta Services Inc (PWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Quanta Services Inc — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.59 (market cap $6.04B), while Quanta Services Inc trades at $700.31 (market cap $103.03B). The key difference: Quanta Services Inc is far larger — about 17.1× Iovance Biotherapeutics Inc. Common Stock's market cap, and Quanta Services Inc pays a 0.06% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Quanta Services Inc for 62 Days on average.
| IOVA | PWR | |
|---|---|---|
Market Cap | $6.04B | $103.03B |
Volume | 14,805,993 | 977,892 |
Sector | Health | Industrials |
52-Week High | $14.82 | $785.24 |
52-Week Low | $1.81 | $412.21 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $5.97B | $109.13B |
Dividend Yield | — | 0.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PWR trades at $701.01, down slightly by 0.01% on the day, with a bullish technical signal and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth is robust, climbing from $17.1B in 2022 to $28.5B in 2025, though net margins remain modest at 4.03%. A record backlog of $53B and positive news on AI infrastructure demand highlight near-term catalysts.
Outlook is positive given earnings momentum and sector tailwinds, but high valuation ratios (P/E of 78.41) and execution risks on large projects pose challenges. With 75% of analysts rating it a Buy and a consensus price target of $802.08, upside potential exists if growth sustains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Quanta Services Inc
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →
